SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 106 filers reported holding SURFACE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $32,747 | -95.5% | 37,657 | -96.4% | 0.00% | -100.0% |
| Q1 2023 | $731,055 | -14.8% | 1,046,157 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $857,849 | -21.2% | 1,046,157 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,089,000 | -36.6% | 1,046,772 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,717,000 | +24428.6% | 1,047,178 | +41454.7% | 0.00% | – |
| Q1 2022 | $7,000 | -86.0% | 2,520 | -76.1% | 0.00% | – |
| Q4 2021 | $50,000 | +2.0% | 10,553 | +62.8% | 0.00% | – |
| Q3 2021 | $49,000 | -86.0% | 6,482 | -86.2% | 0.00% | – |
| Q2 2021 | $351,000 | +160.0% | 47,112 | +173.1% | 0.00% | – |
| Q1 2021 | $135,000 | -18.2% | 17,248 | -3.5% | 0.00% | – |
| Q4 2020 | $165,000 | +8150.0% | 17,880 | +1295.8% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 1,281 | +0.5% | 0.00% | – |
| Q3 2019 | $2,000 | -60.0% | 1,275 | -25.1% | 0.00% | – |
| Q2 2019 | $5,000 | -68.8% | 1,703 | -50.7% | 0.00% | – |
| Q1 2019 | $16,000 | +60.0% | 3,451 | +44.8% | 0.00% | – |
| Q4 2018 | $10,000 | -54.5% | 2,384 | +19.3% | 0.00% | – |
| Q3 2018 | $22,000 | +29.4% | 1,998 | +91.4% | 0.00% | – |
| Q2 2018 | $17,000 | – | 1,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |